Related Experiment Videos

Mapping genes and pathways in autoimmune disease

Anne Spurkland1, Ludvig M Sollid

  • 1Institute of Basic Medical Sciences, University of Oslo, Rikshospitalet University Hospital, Oslo N-0317, Norway. anne.spurkland@medisin.uio.no

Insights

Identifying new genes and pathways for T-cell activation could lead to new therapies for autoimmune diseases and cancer. This review explores alternative strategies and highlights the importance of precise patient phenotyping for future research.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • T-cell activation is crucial for immune responses and implicated in autoimmune diseases and cancer.
  • Recent genomic advances necessitate re-evaluating strategies for identifying novel disease-related genes and pathways.
  • Understanding T-cell regulation is key to developing targeted immunotherapies.

Purpose of the Study:

  • To review alternative strategies for identifying novel genes and pathways controlling T-cell activation.
  • To present recent findings from studies in rodents and humans.
  • To emphasize the importance of detailed phenotyping in disease research.

Main Methods:

  • Review of current literature on T-cell activation pathways.
  • Analysis of genetic studies in model organisms (rodents) and human populations.
  • Discussion of advanced molecular biology and imaging techniques for phenotyping.

Main Results:

  • Identification of specific genes like murine Roquin and Ncf1, and human PTPN22 involved in T-cell regulation.
  • Demonstration of alternative strategies yielding insights into disease pathways.
  • Highlighting the utility of advanced phenotyping to reduce clinical heterogeneity.

Conclusions:

  • Novel genes and pathways controlling T-cell activation offer therapeutic potential for immune-related disorders.
  • Alternative research strategies and precise phenotyping are essential for advancing the field.
  • Further investigation into identified genes and refined patient stratification will accelerate the development of effective treatments.

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...